drugset / Trial / NCT00631124

A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

NCT00631124

Phase 2 Completed 103 enrolled Bayer
RandomizedParallel-groupDouble-blindPrevention

Summary

Investigation of a new pill containing an estrogen and a progestin in order to monitor the inhibition of the ovulation in young healthy females over 3 treatment cycles

Timeline

Start
2008-02
Primary completion
2008-10
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified Oral
Subject drospirenone Unknown Oral

Indications

No indication recorded.